TrialOrphanet journal of rare diseases2022

Long-term safety and efficacy of gene-corrected autologous keratinocyte grafts for recessive dystrophic epidermolysis bullosa.

Jodi Y So et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.